unique model that pioneers a new medical therapy which with stage 4 cancer patients, who were given up by standard of care, showed a 65% efficacy even where these patients had been written off as having no cure and hopeless. This set in motion the passing of -toexperimental personalized therapy, further substantiating validity and efficacy of such treatments. However, Catanzaro was forced to retire from clinical practice in 2017 resulting from treatment that was so successful that it gained the attention of the Chief of Seattle Swedish Cancer Institute Breast Cancer Center.
Cancer Free Patient Barred from Treatment
A triple negative breast cancer patient came to Dr. Catanzaro who had a very large tumor, the size of a melon, growing on a mastectomy site.
This was causing the patient to bleed and she needed to have a blood transfusion every three days to stay alive. The patient was being treated by the Chief of Seattle Swedish Breast Cancer Center without having a desired response. This oncologist and her surgical team gave the patient 30 days to live and left her with no hope. She was referred to Dr. Catanzaro and his center and she had a personalized immune vaccine using peptides identified by protein testing isolated from her urine. The identified peptides were manufactured specifically for her and administered as an injection. In three weeks, her tumor broke off in chunks. Then in three months her tumor was gone, her bleeding stopped, and she is presently 8 years cancer free. with increased quality of health. There are patients now living 10 years out with no recurrence of their disease.
Catanzaro Is Not A Novice
Catanzaro is highly regarded in the integrative medicine community. 
Collaborative Partners and Subsidiaries
This indeed is regenerative medicine revolutionized at the core and is attracting the attention of physicians and practitioners globally. Dr.
Andrew Dickens of Dayspring Cancer Clinic in Scottsdale Arizona, with a practice based on a focus of regenerative / personalized medicine, has joined Neo7Logix. He is partnering with this design in Arizona and interacting with other colleagues nationally and globally.
Other nationally known physicians are also inquiring and engaging with Neo7Logix.
Dr. Kaushik Deb, founder, technopreneur and CEO of DiponEd
Biointelligence is partnering with Neo7Logix and is forming Neo7
Biointelligence of India. A subsidiary located in Bangalore. Kaushik has several medical centers and patients ready to receive the design.
Neo7Logix has other subsidiary interests in China, Russia and Mexico.
PBIMA; A Personalized Regenerative Design
Personalized regenerative therapy is a simple process that solution for the individual patient to defend and regulate against solution for the individual using a unique design that custom fits that individual.
Conclusion
Regenerative physicians and practitioners are true revolutionaries for the advancement of medicine and healthcare. In fact, the FDA has a designation called RMAT Regenerative Medicine Advanced Therapy designation (https://www.fda.gov/vaccines-blood-biologics/cellulargene-therapy-products/regenerative-medicine-advanced-therapydesignation) in order to expedite the hopeful advances as described in this article. Precision and personalization are pivotal in creating diverse, novel approaches unique to the patient in an expanding drug for the disease, it's about creating the unique solution for the Sincerely, Dr. Catanzaro, and Dr. Andrew
Author Contribution
Dr. Catanzaro, and Dr. Andrew Dickens worked for the development of revolutionary changes in healthcare.
